Active — Not RecruitingNot Applicable

Bioavailability of Vitamin D(25(OH)D) and Omega-3 Fatty Acid (DHA) Enhanced Chicken

United States84 participantsStarted 2021-12-04

Plain-language summary

The purpose of the research is to evaluate if chicken or eggs obtained from chickens that are fed a diet that contains omega-3 fatty acids (DHA/EPA), or vitamin D (as 25(OH)D) provides additional health benefits by improving the status of omega-3 fatty acids or 25(OH)D in healthy adults who eat this bioenhanced chicken or eggs.

Who can participate

Age range18 Years – 35 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * healthy adults * Non-smoking * Age between 18- 35 yo * Females: premenopausal and not pregnant or lactating * Body mass index (BMI) between 18 - 30 kg/m2. * No preexisting medical complications (such as eating disorders, gastrointestinal disorders, malabsorption diseases, or taking medications known to influence iron homeostasis) Exclusion Criteria: * BMI \<18 or \> 30 kg/m2, * Age \<18 y or \> 50y, * Smoking * Pregnancy, lactating * Have gastrointestinal disorders/malabsorption diseases/dietary restrictions/medication use of medications known to impact DHA/EPA or Vitamin D 25(OH)D absorption * Take vitamin and mineral supplementations

What they're measuring

Concentration of plasma DHA concentrations

Timeframe: Baseline, and time course of 1 hour, 2 hour, 4 hour and 8 hour post meal

Concentrations of serum 25(OH)D, vitamin D2, vitamin D3, 1,25(OH)2D and 24,25(OH)2D3 and vitamin D binding protein

Timeframe: Baseline, and time course of week 2, week 4, week 6, week 8

Trial details

NCT IDNCT05248737

SponsorCornell University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-11

View on ClinicalTrials.gov More Nutrition, Healthy trials